The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials

Non-alcoholic fatty liver disease (NAFLD11Non-alcoholic fatty liver disease) is the most frequent chronic liver disorder worldwide. Currently, no pharmacological treatment has been approved for NAFLD. Probiotics have been suggested as a potential therapy for NAFLD. The aim of this systematic review...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes and its complications 2024-08, Vol.38 (8), p.108780, Article 108780
Hauptverfasser:	Mozaffari, Sadegh, Aliari, Mahdeyeh, Emamgholipour, Solaleh, Hosseini, Hossein, Amirkiasar, Pedram Rezaei, Zare, Mina, Katsiki, Niki, Panahi, Ghodratollah, Sahebkar, Amirhossein
Format:	Artikel
Sprache:	eng
Schlagworte:	Bias Cholesterol Clinical trials Handbooks Inflammation Insulin resistance Intervention Lipids Liver Liver diseases Meta-analysis Metabolic indices Metabolism Metabolites Microbiota Non-alcoholic fatty liver disease Prebiotics Probiotics Steatosis Systematic review Triglycerides Tumor necrosis factor-TNF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!